Literature DB >> 4813079

Efficacy and residual effect evaluation of a new hypnotic, triazolam.

W Veldkamp, R N Straw, C M Metzler, H V Demissianos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4813079     DOI: 10.1002/j.1552-4604.1974.tb02299.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  19 in total

1.  Mood and performance of poor sleepers during repeated use of flurazepam.

Authors:  M W Church; L C Johnson
Journal:  Psychopharmacology (Berl)       Date:  1979-03-28       Impact factor: 4.530

2.  Effects of benzodiazepines on psychomotor performance.

Authors:  J R Wittenborn
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

3.  Residual and acute effects of flurazepam and triazolam in normal subjects.

Authors:  C Gorenstein; V Gentil
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

4.  Triazolam intoxication.

Authors:  N E McKinnon
Journal:  Can Med Assoc J       Date:  1982-04-15       Impact factor: 8.262

5.  Activity of the hypnotics, flunitrazepam and triazolam, in man.

Authors:  A N Nicholson; B M Stone
Journal:  Br J Clin Pharmacol       Date:  1980-02       Impact factor: 4.335

6.  Hypnotics and hangover.

Authors:  J Chick
Journal:  Br Med J       Date:  1980-05-31

7.  A practical guide to prescribing hypnotic benzodiazepines.

Authors:  M Lader
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

8.  Flurazepam hydrochloride and its principal metabolites: behavioural studies in the monkey (Macaca mulatta).

Authors:  C M Bradley; A N Nicholson
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Effects of triazolam (0.5 mg) on sleep, performance, memory, and arousal threshold.

Authors:  C L Spinweber; L C Johnson
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 10.  Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia.

Authors:  G E Pakes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.